Date : December 2024
The global pharmaceutical CRO market size is estimated to hit around USD 84.90 billion by 2033, increasing from USD 41.50 billion in 2023 with a CAGR of 7.42% from 2023 to 2033. The top companies operating in the pharmaceutical CRO are Thermo Fisher Scientific Inc., Medpace, IQVIA, CTI Clinical Trial & Consulting, Parexel International (MA) Corporation., ICON plc, Laboratory Corporation of America Holdings, WuXi AppTec, Veeda Clinical Research, and Others.
Report Coverage | Details |
Market Size by 2033 | USD 84.90 Billion |
Market Size in 2023 | USD 41.50 Billion |
Market Growth Rate from 2024 to 2033 | CAGR of 7.42% |
Largest Market | Asia Pacific |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | Type, Molecule Type, Therapeutic Areas, Service, and Regions |
Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East, & Africa |
We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344